Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record.

New Recombinant Serotypes of AAV Vectors

Gao, Guangping, Vandenberghe, Luk, Wilson, James · 2005 · Current Gene Therapy

Abstract

AAV based vectors can achieve stable gene transfer with minimal vector related toxicities. AAV serotype 2 (AAV2) is the first AAV that was vectored for gene transfer applications. However, the restricted tissue tropism of AAV and its low transduction efficiency have limited its further development as vector. Recent studies using vectors derived from alternative AAV serotypes such as AAV1, 4, 5 and 6 have shown improved potency and broadened tropism of the AAV vector by packaging the same vector genome with different AAV capsids. In an attempt to search for potent AAV vectors with enhanced performance profiles, molecular techniques were employed for the detection and isolation of endogenous AAVs from a variety of human and non-human primate (NHP) tissues. A family of novel primate AAVs consisting of 110 non-redundant species of proviral sequences was discovered and turned to be prevalent in 18-19% of the tissues evaluated. Phylogenetic and functional analyses revealed that primate AAVs are segregated into clades based on phylogenetic relatedness. The members within a clade share functional and serological properties. Initial evaluation in mouse models of vectors based on these novel AAVs for tissue tropism and gene transfer potency led to the identification of some vector with improved gene transfer to different target tissues. Gene therapy treatment of several mouse and canine models with novel AAV vectors achieved long term phenotypic corrections. Vectors based on new primate AAVs could become the next generation of efficient gene transfer vehicles for various gene therapy applications.

Overview

Integrity signals

Registry

Crossref · 10.2174/1566523054065057

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 489

Metadata

Authors
Gao, G., Vandenberghe, L., & Wilson, J.
Affiliations
University of Pennsylvania (US)
Venue
Current Gene Therapy
Published
2005-06-01
Volume
5
Issue
3
Pages
285-297
ISSN
1566-5232 (ISSN-L)
OpenAlex
W2125160350
Cited by
487
References
0
Citations by year
2026: 6 · 2025: 6 · 2024: 14 · 2023: 12 · 2022: 20 · 2021: 19 · 2020: 15 · 2019: 18 · 2018: 18 · 2017: 20 · 2016: 15 · 2015: 27 · 2014: 29 · 2013: 33 · 2012: 33
FWCI
16.90
Type
journal article
Language
en
Open access
closed
Locations
  • Current Gene Therapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
Keywords
adeno-associated virus vectors, AAV capsid, tissue tropism, proviral sequences, AAV gene therapy, canine model
MeSH terms
Dependovirus, Animals, Genetic Vectors, Humans, Phylogeny, Recombination, Genetic, Genetic Therapy, Genome, Viral, Gene Transfer Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New Recombinant Serotypes of AAV Vectors. https://app.cochat.ai/papers/10.2174/1566523054065057
The paper
Gao, G., Vandenberghe, L., & Wilson, J. (2005). New Recombinant Serotypes of AAV Vectors. Current Gene Therapy. https://doi.org/10.2174/1566523054065057

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.